Yi-Ling Wu Selected Research

Infarction (Infarctions)

7/2012	PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow.
10/2010	Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Ling Wu Research Topics

Disease

18	Stroke (Strokes) 01/2022 - 09/2007
9	Ischemic Stroke 01/2022 - 10/2013
7	Atrial Fibrillation 01/2021 - 08/2009
5	Heart Failure 01/2021 - 01/2017
5	Hemorrhage 12/2020 - 02/2016
4	Intracranial Hemorrhages (Intracranial Hemorrhage) 08/2019 - 10/2013
4	Diabetes Mellitus 01/2019 - 01/2016
3	Atherosclerosis 01/2022 - 01/2010
3	Body Weight (Weight, Body) 01/2022 - 03/2018
3	Neoplasms (Cancer) 05/2019 - 11/2012
3	Myocardial Ischemia (Ischemic Heart Diseases) 03/2018 - 10/2010
3	Myocardial Infarction 01/2018 - 12/2014
2	Hemorrhagic Stroke 01/2022 - 02/2016
2	Cerebral Hemorrhage 11/2019 - 08/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 08/2019 - 01/2019
2	Reperfusion Injury 03/2018 - 10/2010
2	Transient Ischemic Attack 01/2017 - 10/2013
2	Critical Illness (Critically Ill) 01/2015 - 01/2013
2	Infarction (Infarctions) 07/2012 - 10/2010
2	Ischemia 07/2012 - 10/2010
2	Inflammation (Inflammations) 09/2008 - 11/2007
1	Obesity 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2020
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 08/2019
1	Arteriovenous Fistula 02/2019
1	Fistula 02/2019
1	Reproductive Tract Infections 01/2019
1	Urinary Tract Infections (Urinary Tract Infection) 01/2019
1	Coronary Disease (Coronary Heart Disease) 01/2019
1	Death (Near-Death Experience) 01/2018
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2018
1	Diabetic Foot 01/2018
1	Embolism (Embolus) 07/2017
1	Heart Valve Diseases (Valvular Heart Disease) 07/2017
1	Hypertension (High Blood Pressure) 02/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Bone Fractures (Bone Fracture) 01/2017
1	Weight Gain 01/2017
1	Insulin Resistance 01/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2016
1	Neoplasm Metastasis (Metastasis) 06/2014

Drug/Important Bio-Agent (IBA)

6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2020 - 10/2013
5	AnticoagulantsIBA 12/2020 - 01/2016
5	tongxinluoIBA 03/2018 - 09/2007
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2016
3	RivaroxabanIBA 12/2020 - 07/2017
3	Dabigatran FDA Link 12/2020 - 07/2017
3	Vitamin K FDA Link 12/2020 - 07/2017
3	edoxabanIBA 12/2020 - 07/2017
3	apixabanIBA 12/2020 - 07/2017
3	Warfarin (Coumadin)FDA LinkGeneric 12/2018 - 02/2016
3	Proteins (Proteins, Gene)FDA Link 01/2015 - 06/2010
2	oxidized low density lipoproteinIBA 01/2022 - 01/2010
2	ORALIT (ORS)IBA 11/2019 - 12/2018
2	Pioglitazone (Actos)FDA Link 01/2019 - 01/2017
2	Blood Glucose (Blood Sugar)IBA 01/2019 - 03/2018
2	N(4)-oleylcytosine arabinosideIBA 12/2018 - 07/2017
2	omega-Chloroacetophenone (Mace)IBA 01/2017 - 12/2014
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017 - 01/2016
2	CreatinineIBA 01/2015 - 01/2013
2	Clopidogrel (Plavix)FDA Link 12/2014 - 10/2013
2	protein kinase modulatorIBA 07/2012 - 10/2010
2	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 07/2012 - 10/2010
2	salicylhydroxamic acid (SHAM)IBA 07/2012 - 10/2010
2	Creatine Kinase (Creatine Phosphokinase)IBA 07/2012 - 10/2010
2	Capsules (Microcapsules)IBA 09/2011 - 09/2007
1	Proprotein Convertase 9IBA 01/2022
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 01/2022
1	jinlidaIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Ezetimibe (Zetia)FDA Link 01/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2020
1	AldehydesIBA 01/2020
1	ChitosanIBA 01/2020
1	AcidsIBA 01/2020
1	Labetalol (Normodyne)FDA LinkGeneric 11/2019
1	Antihypertensive Agents (Antihypertensives)IBA 11/2019
1	Nifedipine (Adalat)FDA LinkGeneric 11/2019
1	Captopril (Capoten)FDA LinkGeneric 11/2019
1	Sodium-Glucose Transport ProteinsIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019
1	VLDL LipoproteinsIBA 03/2018
1	Apolipoproteins E (ApoE)IBA 03/2018
1	CholesterolIBA 03/2018
1	HDL CholesterolIBA 03/2018
1	Triglycerides (Triacylglycerol)IBA 03/2018
1	VLDL CholesterolIBA 03/2018
1	Insulin (Novolin)FDA Link 01/2018
1	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2018
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2018
1	poly-N-acetyllactosamineIBA 06/2014

Therapy/Procedure

10	Therapeutics 01/2022 - 10/2013
2	Renal Dialysis (Hemodialysis) 02/2019 - 02/2016
1	Catheter Ablation 01/2021
1	Palliative Care (Palliative Therapy) 05/2019
1	Punctures 02/2019
1	Surgical Amputation (Amputations) 01/2018
1	Drug Tapering 08/2017